FY2025 EPS Estimate for Organigram Global Reduced by Analyst

Organigram Global Inc. (NASDAQ:OGI) – Research analysts at Atb Cap Markets lowered their FY2025 EPS estimates for Organigram Global in a report released on Wednesday, August 13th. Atb Cap Markets analyst F. Gomes now expects that the company will post earnings per share of $0.05 for the year, down from their previous forecast of $0.07. The consensus estimate for Organigram Global’s current full-year earnings is ($0.19) per share. Atb Cap Markets also issued estimates for Organigram Global’s FY2027 earnings at $0.04 EPS.

Separately, Wall Street Zen cut shares of Organigram Global from a “hold” rating to a “sell” rating in a research note on Saturday.

Organigram Global Price Performance

Shares of Organigram Global stock opened at $1.43 on Monday. The firm’s fifty day simple moving average is $1.43 and its 200-day simple moving average is $1.27. The stock has a market capitalization of $191.66 million, a price-to-earnings ratio of 28.61 and a beta of 1.45. Organigram Global has a 12 month low of $0.85 and a 12 month high of $2.08.

Organigram Global (NASDAQ:OGI) last released its quarterly earnings data on Wednesday, August 13th. The company reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.02). Organigram Global had a negative return on equity of 8.19% and a net margin of 2.86%. The company had revenue of $50.49 million for the quarter, compared to analyst estimates of $68.04 million.

Hedge Funds Weigh In On Organigram Global

Several institutional investors have recently bought and sold shares of the company. Tidal Investments LLC increased its stake in Organigram Global by 4.9% in the 2nd quarter. Tidal Investments LLC now owns 2,646,879 shares of the company’s stock valued at $3,573,000 after buying an additional 124,356 shares during the period. Renaissance Technologies LLC increased its stake in Organigram Global by 2.4% in the 4th quarter. Renaissance Technologies LLC now owns 914,648 shares of the company’s stock valued at $1,473,000 after buying an additional 21,200 shares during the period. Dimensional Fund Advisors LP increased its stake in Organigram Global by 13.8% in the 4th quarter. Dimensional Fund Advisors LP now owns 359,739 shares of the company’s stock valued at $579,000 after buying an additional 43,721 shares during the period. Baader Bank Aktiengesellschaft acquired a new position in Organigram Global in the 2nd quarter valued at $338,000. Finally, Vontobel Holding Ltd. increased its stake in Organigram Global by 140.5% in the 2nd quarter. Vontobel Holding Ltd. now owns 69,753 shares of the company’s stock valued at $94,000 after buying an additional 40,753 shares during the period. 34.63% of the stock is owned by institutional investors and hedge funds.

Organigram Global Company Profile

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.